Status:
UNKNOWN
Acupressure and Qigong in Chronic Fatigue Post COVID-19.
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Karl and Veronica Carstens Foundation
Conditions:
COVID-19
Post-COVID-19 Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
International observational studies confirm the high incidence of post-infectious residual syndrome after infection with severe acute respiratory syndrome corona virus 2 (SARS-COV2), which can occur i...
Detailed Description
Prospective two-arm (parallel groups) randomised controlled confirmatory intervention study with mixed methods approach in 2x 100 patients (n=200). Intervention: self-applied acupressure and online Q...
Eligibility Criteria
Inclusion
- diagnosis of chronic fatigue (after SARS-CoV2 infection)
- with at least 3 of 7 criteria at time of study inclusion: sleeping disorder, headaches, joint pain/muscle pain, anxiety/depression, memory impairment/ concentration problems, anosmia, exercise intolerance.
- acute SARS-CoV2 infection at least 12 weeks ago
- age 18-60 years
- visual analogue scale (0-100 mm) physical resilience of maximum 60 mm
- SF-36 physical function of maximum 65
- technically equipped to participate in the online intervention and willing to follow the study procedure, acupressure and Qigong to perform the exercise series at home
- written informed consent available.
Exclusion
- fatigue already present before the SARS-CoV2 infection
- other underlying diseases leading to symptoms of chronic fatigue, such as major depression, oncological diseases, multiple sclerosis, fibromyalgia and drug abuse
- other serious underlying diseases, such as severe pulmonary, cardiac, psychiatric or infectious diseases, which could interfere with study participation or affect the results
- ongoing opioid therapy or opioid therapy in the week prior to study entry
- chronic use of cannabinoids before or during the study.
- start of psychotherapy or interruption of ongoing therapy during study participation
- female participants: pregnancy or breastfeeding
- participation in another clinical intervention study during study participation
- ongoing pension procedure or planned claiming of a pension procedure due to disability
- planned inpatient rehabilitation measures during study participation due to PostCOVID-19 -
Key Trial Info
Start Date :
June 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05289154
Start Date
June 14 2022
End Date
October 1 2023
Last Update
January 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité Universitätsmedizin Campus Mitte
Berlin, Germany, 10117